Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Toronto Stock Exchange  >  Aphria Inc    APH   CA03765K1049

APHRIA INC (APH)
Mes dernières consult.
Most popular
  Report  
 SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Toronto Stock Exchange
04/16/2018 04/17/2018 04/18/2018 04/19/2018 04/20/2018 Date
12.24 11.34 11.14 11 10.6 Last
7709090 5483378 4332703 2639826 3444427 Volume
+7.37% -7.35% -1.76% -1.26% -3.64% Change
Financials (CAD)
Sales 2018 37,1 M
EBIT 2018 -8,13 M
Net income 2018 31,4 M
Finance 2018 93,9 M
Yield 2018 -
Sales 2019 218 M
EBIT 2019 33,1 M
Net income 2019 63,2 M
Finance 2019 50,1 M
Yield 2019 -
P/E ratio 2018 56,78
P/E ratio 2019 39,26
EV / Sales2018 57,2x
EV / Sales2019 9,93x
Capitalization 2 215 M
More Financials
Company
Aphria, Inc. engages in the production and supply of medical marijuana.Its products include alien dawg, champlian indica, grower's blend, champlain-sativa and blueberry.The company was founded by Cole Cacciavillani and John Cervini on June 22, 2011 and is headquartered in Leamington, Canada. ... 
Sector
Pharmaceuticals
Calendar
-
More about the company
Surperformance© ratings of Aphria Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on APHRIA INC
02/02APHRIA : Pot company Aphria to sell stake in U.S. cannabis grower
RE
01/03Canadian pot stocks surge on new U.S. fund, California legalization
RE
01/02TSX notches record high as resource shares climb
RE
2017IIROC Trade Resumption - Aphria Inc.
NE
2017IIROC Trade Halt - Aphria Inc.
NE
2017Aphria bets C$10 million on Canada's recreational marijuana market
RE
2017TSX ends lower as banks, mining stocks weigh
RE
2017APHRIA : Canada's Aphria to sell medical marijuana to Loblaws' pharmacy chain
RE
2017IIROC Trade Resumption - Aphria Inc.
NE
2017IIROC Trade Halt - Aphria Inc.
NE
More news
Sector news : Pharmaceuticals - NEC
08:16aSHIRE PLC SHIRE PLC : Rule 2.9 Announcement
DJ
04/21TAKEDA PHARMACEUTICAL : Keeps Courting Shire -- WSJ
DJ
04/20GRAIN HIGHLIGHTS : Top Stories of the Day
DJ
04/20Japan's Takeda sweetens $62 billion Shire offer
RE
04/20SHIRE PLC SHIRE PLC : Statement Re Proposal From -2-
DJ
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
03/16Did Aurora Overpay For CanniMed? 
03/14Marijuana Stocks And Industry Drivers For 2018 
03/13Marijuana Sales To Start As Soon As August This Year 
03/12WEEKLY CANNABIS REPORT : Ontario And Canopy In The News 
03/08Could Aurora Lower Its Bid For CanniMed Too? 
Chart APHRIA INC
Duration : Period :
Aphria Inc Technical Analysis Chart | APH | CA03765K1049 | 4-Traders
Income Statement Evolution
Consensus
 
Mean consensus OUTPERFORM
Number of Analysts 7
Average target price 25,0  CAD
Spread / Average Target 136%
EPS Revisions
Managers
NameTitle
Victor Neufeld President & Chief Executive Officer
Cole Cacciavillani Chief Operating Officer & Director
Carl A. Merton Chief Financial Officer
John Cervini Director & VP-Infrastructure & Technology
Gary Leong Chief Scientific Officer
Sector and Competitors
1st jan.Capitalization (M$)
APHRIA INC-45.45%1 734
JOHNSON & JOHNSON-9.35%339 783
PFIZER1.13%217 897
NOVARTIS-7.67%204 972
ROCHE HOLDING LTD.-12.52%191 890
MERCK AND COMPANY4.55%158 571